ID   HRA-16
AC   CVCL_2507
SY   HRA 16; HRA16
DR   ECACC; 06061905
DR   GEO; GSM1448117
DR   Wikidata; Q54895213
DR   Ximbio; 152464
RX   PubMed=3718830;
RX   PubMed=25926053;
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC   Omics: Transcriptome analysis by microarray.
CC   Discontinued: Ximbio; 152464; probable.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9,13
ST   D16S539: 10,13
ST   D21S11: 28
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 9.3
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
RX   PubMed=3718830; DOI=10.1038/bjc.1986.132;
RA   Kirkland S.C., Bailey I.G.;
RT   "Establishment and characterisation of six human colorectal
RT   adenocarcinoma cell lines.";
RL   Br. J. Cancer 53:779-785(1986).
RX   PubMed=25926053; DOI=10.1038/ncomms8002;
RA   Medico E., Russo M., Picco G., Cancelliere C., Valtorta E., Corti G.,
RA   Buscarino M., Isella C., Lamba S., Martinoglio B., Veronese S.,
RA   Siena S., Sartore-Bianchi A., Beccuti M., Mottolese M.,
RA   Linnebacher M., Cordero F., Di Nicolantonio F., Bardelli A.;
RT   "The molecular landscape of colorectal cancer cell lines unveils
RT   clinically actionable kinase targets.";
RL   Nat. Commun. 6:7002.1-7002.10(2015).